| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Taurultam |
牛磺胺 |
38668-01-8 |
详细
|
| Ipragliflozin |
伊格列净 |
761423-87-4 |
详细
|
| Metronidazole Impurity F |
O-羟乙基甲硝唑 |
16156-94-8 |
详细
|
| PX-478 dihydrochloride |
(S)-4-(2-氨基-2-羧乙基)-N,N-双(2-氯乙基)环己-1,3-二苯胺氧化物二盐酸盐 |
685898-44-6 |
详细
|
| TPT-260 2HCl |
NSC 55712 |
2076-91-7 |
详细
|
| PTC-209 |
PTC-209 |
315704-66-6 |
详细
|
| MDK74978 |
化合物MULTI-KINASE INHIBITOR I |
778274-97-8 |
详细
|
| Presatovir |
GS-5806 |
1353625-73-6 |
详细
|
| KIRA6 |
CS-2625 |
1589527-65-0 |
详细
|
| BAY 41-4109 |
298708-81-3 |
298708-81-3 |
详细
|
| Indacaterol Impurity 2 |
茚达特罗杂质12 |
1026461-20-0 |
详细
|
| Astragaloside A |
黄芪甲苷 |
83207-58-3 |
详细
|
| BEC HCl |
BEC HCL, 一个竞争性的 ARGINASE II抑制剂 |
222638-67-7 |
详细
|
| (R)-(-)-Nirvanol |
5-乙基-5-苯基海因 |
65567-32-0 |
详细
|
| Fenoxaprop-p-ethyl |
精恶唑禾草灵 |
71283-80-2 |
详细
|
| Sufugolix |
SUFUGOLIX |
308831-61-0 |
详细
|
| Liproxstatin-1 |
利普司他丁-1 |
950455-15-9 |
详细
|
| UK-371804 |
化合物UK371804 |
256477-09-5 |
详细
|
| ARS-1630 |
ARS-1630 |
1698055-86-5 |
详细
|
| 5-Aminosalicylic acid |
5-氨基水杨酸 |
89-57-6 |
详细
|
| EIPA |
5-(N-乙基-N-异丙基)阿米洛利 |
1154-25-2 |
详细
|
| Maxacalcitol |
马沙骨化醇 |
103909-75-7 |
详细
|
| Afobazole |
4-(2-(5-ETHOXY-1H-BENZO[D]IMIDAZOL-2-YLTHIO)ETHYL)MORPHOLINE |
173352-21-1 |
详细
|
| GGTI-2418 |
化合物 T11396 |
501010-06-6 |
详细
|
| RKI-1313 |
1-(3-METHOXYBENZYL)-3-(4-(PYRIDIN-4-YL)THIAZOL-2-YL)UREA |
1342276-76-9 |
详细
|
| T.cruzi Inhibitor |
N-苄基-N-甲基-1-(4-(三氟甲基)苄基)哌啶-3-甲酰胺 |
1350920-22-7 |
详细
|
| ORY-1001 dihydrochloride |
N1-(反式-2-苯基环丙基)环己烷-1,4-二胺二盐酸盐 |
1431326-61-2 |
详细
|
| PF-1355 |
1435467-38-1 |
1435467-38-1 |
详细
|
| 4-(1-Chloroethyl)-1,2-dimethylbenzene |
右美托咪啶 3 |
104245-83-2 |
详细
|
| Dehydroxy Mirabegron Hydrochloride Salt |
米拉贝隆杂质 |
1581284-79-8 |
详细
|
| Sulfometuron methyl |
甲嘧磺隆 |
74222-97-2 |
详细
|
| (S)-(+)-Nirvanol |
S-(+)-N-去甲基美芬妥英 |
65567-34-2 |
详细
|
| trans-maxacalcitol |
反式马沙骨化醇 |
929721-98-2 |
详细
|
| Probucol Disuccinate |
普罗布考 |
216168-45-5 |
详细
|
| LTI-291 |
LTI-291 |
1919820-28-2 |
详细
|
| 1β-maxacalcitol |
1β-maxacalcitol |
169218-34-2 |
详细
|
| phensuximide |
密朗丁 |
86-34-0 |
详细
|
| Thymulin (acetate) |
血清胸腺因子 |
63958-90-7 |
详细
|
| MGL-3196 |
MGL-3196 |
920509-32-6 |
详细
|
| Etravirine-[d4] |
麦角菌素D4 |
1142095-93-9 |
详细
|
| Q203 |
Q203 |
1334719-95-7 |
详细
|
| JNJ 63533054 |
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺 |
1802326-66-4 |
详细
|
| FIN56 |
FIN56 |
1083162-61-1 |
详细
|
| EC330 |
LIF抑制剂(EC330) |
2016795-77-8 |
详细
|
| ARS-1323 |
ARS-1323 |
1698024-73-5 |
详细
|
| CA-4948 |
CA-4948 |
1801343-74-7 |
详细
|
| Methyl Aminolevulinate Hydrochloride |
5-氨基酮戊酸甲酯盐酸盐 |
79416-27-6 |
详细
|
| GW4869 |
GW4869 |
6823-69-4 |
详细
|
| Lvguidingan |
LVGUIDINGAN;3;4-DICHLOROPHENYL PROPENYLISOBUTYLAMIDE |
82351-05-1 |
详细
|
| Azeliragon |
阿齐瑞格 |
603148-36-3 |
详细
|
| (±)-Corey lactone diol |
(3AR,4S,5R,6AS)-六氢-5-羟基-4-羟甲基-2H-环戊并[B]呋喃-2-酮 |
54423-47-1 |
详细
|
| JTE-013 |
JTE-013 |
383150-41-2 |
详细
|
| AM095 sodium |
4'-[3-甲基-4-[[[(1R)-1-苯基乙氧基]羰基]氨基]-5-异恶唑基]联苯-4-乙酸钠盐 |
1345614-59-6 |
详细
|
| Ponatinib hydrochloride |
泊那替尼盐酸盐 |
1114544-31-8 |
详细
|
| Maxacalcitol Impurity B |
马沙骨化醇杂质2 |
132071-85-3 |
详细
|
| Afobazole hydrochloride |
CS-1292 |
173352-39-1 |
详细
|
| OTSSP167 hydrochloride |
OTSSP 167 盐酸盐 |
1431698-10-0 |
详细
|
| SUN11602 |
化合物SUN 11602 |
704869-38-5 |
详细
|
| WZB 117 |
WZB-117 |
1223397-11-2 |
详细
|
| SPI-112Me |
化合物SPI--112ME |
1243685-62-2 |
详细
|
| 1-(2,3-Dimethylphenyl)propan-1-ol |
1-(2,3-二甲基苯基)-1-羟基丙烷 |
944268-64-8 |
详细
|
| Tiadinil |
3'-氯-4,4'-二甲基-1,2,3-噻二唑-5-甲酰苯胺 |
223580-51-6 |
详细
|
| BMS-986141 |
化合物 BMS-986141 |
1478711-48-6 |
详细
|
| Coluracetam |
考拉西坦 |
135463-81-9 |
详细
|
| Choline Fenofibrate |
非诺贝特胆碱 |
856676-23-8 |
详细
|
| Revefenacin |
雷芬那辛 |
864750-70-9 |
详细
|
| UNC 3230 |
UNC3230 |
1031602-63-7 |
详细
|
| NVS-PAK1-1 |
NVS-PAK1-1 |
1783816-74-9 |
详细
|
| Indacaterol Impurity 1 |
Indacaterol Impurity 7 |
1403389-05-8 |
详细
|
| Pimecrolimus |
吡美莫司 |
137071-32-0 |
详细
|
| Glutaurine |
磺乙谷酰胺 |
56488-60-9 |
详细
|
| ADT-OH |
5-(4-羟基苯基)-3H-1,2-二硫杂环戊烯-3-硫酮 |
18274-81-2 |
详细
|
| FR 179642 |
米卡芬净杂质 FR-179642 |
168110-44-9 |
详细
|
| (S)-Indacaterol |
茚达特罗杂质 |
1235445-80-3 |
详细
|
| SU 5214 |
合物SU 5214 |
186611-04-1 |
详细
|
| AMG-3969 |
AMG-3969 |
1361224-53-4 |
详细
|
| GSK-7975A |
1253186-56-9 |
1253186-56-9 |
详细
|
| IRAK4-IN-3 |
AZ1495 |
2196204-23-4 |
详细
|
| Atosiban |
阿托西班 |
90779-69-4 |
详细
|
| ROCAGLAMIDE |
楝酰胺 |
84573-16-0 |
详细
|
| IRAK-1-4 Inhibitor I |
IRAK-1-4 抑制剂 I |
509093-47-4 |
详细
|
| Medroxyprogesterone 17-acetate |
醋酸甲羟孕酮 |
71-58-9 |
详细
|
| 4EGI-1 |
4EGI-1 |
315706-13-9 |
详细
|
| GSK-8573 |
GSK8573 |
1693766-04-9 |
详细
|
| eFT-508 |
6'-[(6-氨基-4-嘧啶基)氨基]-8'-甲基螺[环己烷-1,3'(2'H)-咪唑并[1,5-A]吡啶]-1',5'-二酮 |
1849590-01-7 |
详细
|
| SPI 112 |
(Z)-3-(2-(5-(N-(4-氟苄基)氨磺酰基)-2-氧代二氢吲哚-3-亚基)肼基)苯甲酸 |
1051387-90-6 |
详细
|
| MAK683 |
CPD 1111 |
1951408-58-4 |
详细
|
| Prezatide Copper Acetate |
醋肽铜 |
130120-57-9 |
详细
|
| Ovalicin |
抗生素 SL-1846 |
19683-98-8 |
详细
|
| Ipratropium Impurity A |
异丙托溴铵相关物质A |
58005-18-8 |
详细
|
| Imatinib Impurity C |
伊马替尼进口标准杂质C |
938082-57-6 |
详细
|
| CP-609754 |
CP-609754 |
1190094-64-4 |
详细
|
| (E)-KPT330 |
(E)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE |
1421923-86-5 |
详细
|
| EED-226 |
EED226 |
2083627-02-3 |
详细
|
| 1-(3,4-Dimethylphenyl)ethanol |
右美托咪啶 2 |
33967-19-0 |
详细
|
| STK16-IN-1 |
化合物STK16-IN-1 |
1223001-53-3 |
详细
|
| Dropropizine |
羟丙哌嗪 |
17692-31-8 |
详细
|
| Rafigrelide |
RAFIGRELIDE |
1029711-88-3 |
详细
|
| BAY 299 |
BAY-299 |
2080306-23-4 |
详细
|
| EIPA hydrochloride |
EIPA盐酸盐 |
1345839-28-2 |
详细
|